Peter Kuhn

About

Peter Kuhn, Ph.D., is a University Professor and Dean’s Professor of Biological Sciences, Medicine, Biomedical Engineering, Aerospace and Mechanical Engineering, and Urology at the USC Dornsife College of Letters, Arts and Sciences. He is a scientist and entrepreneur with a long-standing commitment to personalized medicine and individualized patient care, focusing on the redesign of cancer care. His research team in physics oncology has discovered new ways of understanding how cancer spreads to the human body and is using those breakthroughs to impact patient care. Dr. Kuhn is a founding member of the Michelson Center for Convergent Biosciences, a co-founder of the USC Michelson Center for Convergent Bioscience Bridge Institute, and the director of the Convergent Science Institute in Cancer (CSI-Cancer). His overarching strategy is to advance understanding of the human body to improve the human condition, with research shedding new light on the mechanisms of cancer spread to develop biologically informed and clinically actionable personalized care strategies.

Research topics

• Computer Science
• Information Retrieval
• Internal medicine
• Medicine
• Data Mining
• Genetics
• Virology
• Cancer research
• Biology
• Oncology

Selected publications

• Modeling the Onset of Symptoms of COVID-19

  Frontiers in Public Health · 2020 · 213 citations

  COVID-19 is a pandemic viral disease with catastrophic global impact. This disease is more contagious than influenza such that cluster outbreaks occur frequently. If patients with symptoms quickly underwent testing and contact tracing, these outbreaks could be contained. Unfortunately, COVID-19 patients have symptoms similar to other common illnesses. Here, we hypothesize the order of symptom occurrence could help patients and medical professionals more quickly distinguish COVID-19 from other re…

  DOI

• Minimum Technical Data Elements for Liquid Biopsy Data Submitted to Public Databases

  Clinical Pharmacology & Therapeutics · 2020 · 44 citations

  BloodPAC is a public-private consortium that develops standards and best practices, organizes

  DOI

• International expert consensus on the clinical integration of circulating tumor cells in solid tumors

  European Journal of Cancer · 2025-10-20 · 4 citations

  article
  PublisherDOI

• Simultaneous expression of epithelial and immune cell markers in circulating tumor cells identified in patients with stage 4 breast cancer

  Communications Medicine · 2025-07-24 · 4 citations

  articleOpen access

  BACKGROUND: Heterogeneous circulating tumor cells (CTCs) have been implicated in the formation of new metastases. However, circulating cells expressing both tumor and immune cell proteins are often dismissed as insignificant findings in CTC studies. METHODS: Two non-contemporaneous blood samples from a metastatic breast cancer patient were analyzed using an enrichment-free platform to identify canonical, epithelial-only CTCs (CD45-/cytokeratin + , epi.CTCs) and CD45 + /cytokeratin+ immune-like C…

  PublisherOA PDFDOI

• Cellular senescence in precancer lesions and early-stage cancers

  Cancer Cell · 2025-11-06 · 4 citations

  article
  PublisherDOI

Recent grants

• NIH Grant P50GM062411

  NIH · $42.0M · 2006

• NIH Grant U54CA143906

  NIH · $4.2M · 2015

• NIH Grant U54GM074961

  NIH · $34.5M · 2010

Frequent coauthors

• Ashley M. Deacon

  367 shared

• Keith O. Hodgson

  Stanford Synchrotron Radiation Lightsource

  349 shared

• Mitchell D. Miller

  Rice University

  345 shared

• Henry van den Bedem

  University of California, San Francisco

  327 shared

• Guenter Wolf

  Stanford Synchrotron Radiation Lightsource

  326 shared

• John Wooley

  University of California, San Diego

  325 shared

• Scott A. Lesley

  293 shared

• Raymond C. Stevens

  ShanghaiTech University

  288 shared

Similar researchers at University of Southern California

• Stephen Chih-Yang Luh-93
• Petros A Ioannouh-81
• Yong Chenh-76